During the past decade, Moss Rehabilitation Research Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Moss Rehabilitation Research Institute" #1 sponsor was "Albert Einstein Healthcare Network" with 5 trials, followed by "Baylor College of Medicine" with 1 trials sponsored, "BrainQ Technologies Ltd." with 1 trials sponsored, "Craig Hospital" with 1 trials sponsored and "Duke University" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Moss Rehabilitation Research Institute" #1 collaborator was "Craig Hospital" with 2 trials as a collaborator, "Moss Rehabilitation Research Institute" with 2 trials as a collaborator, "Spaulding Rehabilitation Hospital" with 2 trials as a collaborator, "TIRR Memorial Hermann" with 2 trials as a collaborator and "University of Pennsylvania" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Moss Rehabilitation Research Institute" are "Traumatic Brain Injury" (5 trials), "Stroke" (2 trials), "Cerebellar Ataxia" (1 trials), "Ischemic Stroke" (1 trials) and "Memory Deficits" (1 trials). Many other conditions were trialed in "Moss Rehabilitation Research Institute" in a lesser frequency.

Most popular intervention types in "Moss Rehabilitation Research Institute" are "Behavioral" (5 trials), "Device" (4 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ASMT" (1 trials), "Amantadine Hydrochloride" (1 trials), "BA-Tech" (1 trials) and "BQ 2.0" (1 trials). Other intervention names were less common.

The vast majority of trials in "Moss Rehabilitation Research Institute" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Moss Rehabilitation Research Institute". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Moss Rehabilitation Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Moss Rehabilitation Research Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".